(1)
Wahiduzzaman, M.; Yasmin, A.; Shahriar Hossain, M.; Dhar, R.; Haider, M. M. Efficacy and Safety of Empagliflozin (SGLT2 Inhibitor) in Bangladeshi Patients With Type 2 Diabetes Mellitus. Int J Res Med Sci 2025, 13, 5150-5154.